share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Clark James David

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Clark James David

西维斯健康 | 4:持股变动声明-高管 Clark James David
美股SEC公告 ·  12/04 06:22

Moomoo AI 已提取核心信息

On 11/30/2024, Clark James David, SVP, Cont & Chief Acct Officer of CVS Health, completed a transaction involving the sale of 86 shares of common stock. The shares were sold at a price of $59.85 each, resulting in a total transaction value of approximately $5,147.1.This transaction was executed to cover the payment of exercise price or tax liability by delivering or withholding securities. Following this transaction, Clark James David holds 15,109 shares directly. The transaction was completed as per the reported details, with no indirect holdings involved.
On 11/30/2024, Clark James David, SVP, Cont & Chief Acct Officer of CVS Health, completed a transaction involving the sale of 86 shares of common stock. The shares were sold at a price of $59.85 each, resulting in a total transaction value of approximately $5,147.1.This transaction was executed to cover the payment of exercise price or tax liability by delivering or withholding securities. Following this transaction, Clark James David holds 15,109 shares directly. The transaction was completed as per the reported details, with no indirect holdings involved.
2024年11月30日,CVS Health高级副总裁兼首席会计官克拉克·詹姆斯·戴维完成了一项涉及出售86股普通股的交易。这些股票以每股59.85美元的价格出售,总交易价值约为5,147.1美元。执行本交易的目的是通过交付或预扣证券来支付行使价或纳税义务的支付。在这笔交易之后,克拉克·詹姆斯·戴维直接持有15,109股股票。根据报告的细节,该交易已完成,不涉及间接持股。
2024年11月30日,CVS Health高级副总裁兼首席会计官克拉克·詹姆斯·戴维完成了一项涉及出售86股普通股的交易。这些股票以每股59.85美元的价格出售,总交易价值约为5,147.1美元。执行本交易的目的是通过交付或预扣证券来支付行使价或纳税义务的支付。在这笔交易之后,克拉克·詹姆斯·戴维直接持有15,109股股票。根据报告的细节,该交易已完成,不涉及间接持股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息